Morgan Stanley (MS) Q2 2026 Earnings Call Transcript

Morgan Stanley reported Q2 net revenues of $21.3B (+27% YoY) and diluted EPS of $3.46 (+62% YoY), with ROTCE rising to 26.6% (from 18.2%). Wealth management delivered record $148.1B organic net new assets and record $8.9B revenues, while institutional securities posted record $11.0B revenues supported by strong equities (+69% YoY) and investment banking ($2.4B, +58% YoY). The firm increased its quarterly dividend by 15% to $1.15/share and announced $1.5B of Q2 buybacks plus a new $20B multiyear repurchase authorization, alongside a 14.8% CET1 ratio (~300 bps above regulatory requirements). Management also projected the AI compute cycle is only 10%-15% complete, with compute spend potentially reaching ~$10T over the next decade, while flagging geopolitical noise as an ongoing risk.

Analysis

MS is becoming less of a “bank beta” trade and more of a capital-markets operating system: when volatility, IPOs, and balance-sheet demand coexist, the firm captures fee income, financing spread, and wallet share simultaneously. That makes the stock structurally advantaged versus BAC/WFC, which are more tied to spread income and less to this mix of equity underwriting, prime brokerage, and advisory monetization. The secondary winner is MUFG, where the Asia partnership effectively gives MS a lower-friction distribution rail into cross-border flows; smaller global banks and boutique platforms with weaker product breadth are at risk of being price-takers.

The key risk is durability. A lot of the wealth NNA looks like employee-linked IPO flows and can fade quickly if public-market windows close or late-stage private deal activity pauses; that is a days-to-months issue, not a multi-year one. Separately, the earnings power is heavily dependent on market regime staying “active but not chaotic”: if equity dispersion collapses, rates volatility stays muted, and M&A remains tentative, the market will haircut the very multiple expansion this quarter supports.

The contrarian miss is that excess capital is not automatically shareholder accretion. Management is signaling a willingness to keep investing organically and opportunistically bolt on assets, which could cap near-term buyback intensity even with a strong CET1 buffer. The real structural upside is 6-18 months out if AI-related financing and capex create a sustained capital-raising cycle; if that thesis is right, MS should keep taking share from EVR-type advisers and from regional banks that cannot intermediate complex flows.

Key Decisions for Investors

• Long MS on pullbacks over the next 2-4 weeks; thesis is operating leverage plus capital returns, with upside if Q3 confirms sequential NII stability and IB pipelines convert.
• Pair trade: long MS / short BAC or WFC for 1-3 months, targeting relative outperformance if markets stay constructive; falsify if trading revenue normalizes faster than fee income expands.
• Alert on MS if workplace NNA decelerates for two consecutive quarters or if IPO-linked flows reverse; that would challenge the sustainability of the wealth multiple in 6-12 months.
• Buy MUFG as a quieter beneficiary of the Asia distribution and FX integration buildout; better risk/reward than chasing MS if investors want international leverage without the same valuation stretch.
• Avoid chasing EVR on this print; if M&A broadens as management expects, boutiques should participate, but MS has the stronger all-weather mix. Revisit only if advisory backlog converts faster than trading activity moderates.